Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger B Cohen

Showing results (31-40 of 208) with videos related to

Pageof 21
Sort By:
Journal of Neuro-Oncology|April 21, 2007
Unexpected dementia following prophylactic cranial irradiation for small cell lung cancer: case reportDavid J D'Ambrosio, Roger B Cohen, Jon Glass, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2013
A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignanciesRoger B Cohen, Steinar Aamdal, Marta Nyakas, et al.
JAMA Network Open|August 19, 2024
Overall Survival, Treatment Duration, and Rechallenge Outcomes With ICI Therapy for Recurrent or Metastatic HNSCCLova Sun, Roger B Cohen, Christopher A D'Avella, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 21, 2018
The association between fatigue and pain symptoms and decreased physical activity after cancerSally A D Romero, Lee Jones, Joshua M Bauml, et al.
Cancer Investigation|January 12, 2005
Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology GroupCorey J Langer, Yi Li, Timothy Jennings, et al.
Cancer Chemotherapy and Pharmacology|July 5, 2006
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumorsHerbert I Hurwitz, Roger B Cohen, J Patrick McGovren, et al.
Head & Neck|June 9, 2026
Clinicogenomic Features and Outcomes of Adenoid Cystic Carcinoma With Central Nervous System Metastases: A Single-Institution Cohort StudyOmar Elghawy, Jack Stylli, Martin Kurian, et al.
Head & Neck|April 17, 2020
Care of immunocompromised patients with head and neck cancer during the COVID-19 pandemic: Two challenging and informative clinical casesAlyssa M Civantos, Ryan M Carey, Gary R Lichtenstein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung CancerStephen J Bagley, Suzanna Talento, Nandita Mitra, et al.
Investigational New Drugs|June 12, 2014
A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neckDaniel W Bowles, Neil Senzer, Diana Hausman, et al.
Pageof 21

Showing results (31-40 of 208) with videos related to

Sort By:
Pageof 21
Journal of Neuro-Oncology|April 21, 2007
Unexpected dementia following prophylactic cranial irradiation for small cell lung cancer: case reportDavid J D'Ambrosio, Roger B Cohen, Jon Glass, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2013
A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignanciesRoger B Cohen, Steinar Aamdal, Marta Nyakas, et al.
JAMA Network Open|August 19, 2024
Overall Survival, Treatment Duration, and Rechallenge Outcomes With ICI Therapy for Recurrent or Metastatic HNSCCLova Sun, Roger B Cohen, Christopher A D'Avella, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 21, 2018
The association between fatigue and pain symptoms and decreased physical activity after cancerSally A D Romero, Lee Jones, Joshua M Bauml, et al.
Cancer Investigation|January 12, 2005
Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology GroupCorey J Langer, Yi Li, Timothy Jennings, et al.
Cancer Chemotherapy and Pharmacology|July 5, 2006
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumorsHerbert I Hurwitz, Roger B Cohen, J Patrick McGovren, et al.
Head & Neck|June 9, 2026
Clinicogenomic Features and Outcomes of Adenoid Cystic Carcinoma With Central Nervous System Metastases: A Single-Institution Cohort StudyOmar Elghawy, Jack Stylli, Martin Kurian, et al.
Head & Neck|April 17, 2020
Care of immunocompromised patients with head and neck cancer during the COVID-19 pandemic: Two challenging and informative clinical casesAlyssa M Civantos, Ryan M Carey, Gary R Lichtenstein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung CancerStephen J Bagley, Suzanna Talento, Nandita Mitra, et al.
Investigational New Drugs|June 12, 2014
A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neckDaniel W Bowles, Neil Senzer, Diana Hausman, et al.
Pageof 21